ArticlePloS one2017

Viability of primary osteoblasts after treatment with tenofovir alafenamide: Lack of cytotoxicity at clinically relevant drug concentrations.

Christian Callebaut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.